00:00Fresh hope for babies born with malaria as the first vaccine safe for infants gets the green light from Swiss regulators.
00:09It's a potential game changer, especially here in Uganda, where over 12 million cases and nearly 16,000 deaths were recorded in 2023.
00:18Until now, the vaccines available were only suitable for older children, making administering them to babies a medical minefield.
00:25We are beginning to get children below six months coming in with malaria.
00:34Some are born with malaria, and that is what we refer to as congenital malaria.
00:39Some come in with infections during the neonatal period, that's below one month.
00:49And the treatment has been quite challenging, because we are giving them the dose that is given to those that are 5 kilograms to 14 kilograms,
01:02which was a bit challenging, because the key question was, was that the right amount for their kind of kilograms?
01:12Because normally those children are below 5 kilograms.
01:15Like the newborns, most of them will be between 2.5 to 4.5.
01:20The newly approved drug, known as Cortem Baby or ReaMet Baby, combines two anti-malarials tailored for infants.
01:30Accurate dosing is critical as mistakes not only risk overdose, but also feel dangerous resistance.
01:36Now that we have this new medicine, we are going to be able to respond to our needs, to our gap.
01:43Otherwise, before the risk was that, when you're not giving accurate treatments, we are seeing the rise of anti-malarial resistance.
01:51That means that the malaria drugs are not working, as they should, because of things like the dosages not being accurate for babies.
01:59Malaria remains the leading cause of illness and death in children under five, including newborns in Uganda.
02:05The new infant-friendly drug will be rolled out in Uganda and seven other countries across Africa, including Burkina Faso and Nigeria.